A New Drug Application (NDA) is a regulatory submission to the Food and Drug Administration (FDA) for the approval of a new pharmaceutical for sale and marketing in the United States. It includes comprehensive data from preclinical studies, clinical trials, and manufacturing processes to demonstrate the drug's safety and efficacy.
